These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-004516-22 The impact of steroid hormones on symptom provocation in patients with premenstrual dysphoric disorder. not-yet-due
Completed, but no date, and reported results 2004-004929-99 Cardiac effects of oxytocin administrated during cesarean section, signs of myocardial ischaemia. bad-data
Ongoing 2005-005565-10 Allopregnanolone effects on short term memory not-yet-due
Not reported 2006-005809-65 An open, fixed order, single center pharmacokinetic study of the influence of St John's wort on the pharmacokinetics and metabolism of fiansteride in healthy male subjects 2007-03-16 due-trials
Ongoing 2008-003123-24 Neuroanatomical and functional abnormalities in patients with aversive effects from oral contraceptives. not-yet-due
Ongoing 2008-003581-26 Pharmacokinetics of levodopa using duodenal levodopa/carbidopa infusion with and without oral COMT inhibitors not-yet-due
Ongoing 2008-005819-18 A comparison of Dysport (100 U/ml) and Botox (100 U/ml) using dose conversion factor 3:1 and 1.7:1 in the treatment of cervical dystonia. not-yet-due
Ongoing 2008-006410-20 Undersökning av en kväveoxidsyntashämmares effekt på smärta hos patienter med kronisk neuropatisk smärta. - Intravenös infusion med metylenblått not-yet-due
Ongoing 2009-010609-35 Is treatment with emollients always beneficial? Comparative biophysical and molecularbiological studies of the skinbarrier function in patients with atopic dermatitis, ichtyosis vulgaris and x-linke... not-yet-due
Exempt 2009-010783-41 Population pharmacokinetic and pharmacodynamic modeling of gabapentin in neuropathic pain - Effect of adjuvant pharmacotherapy not-yet-due
Ongoing 2009-011446-26 A randomized, placebo-controlled, double blind, parallel group phase II study of anti-ESBL IgY for the eradication of ESBL Klebsiella pneumoniae and Escherichia coli in faeces in carriers not-yet-due
Ongoing 2010-023007-10 A neuroscience perspective on anxiety proneness - Sex differences, monoaminergic pathways and treatment response not-yet-due
Completed, but no date, and reported results 2013-000925-30 How common are mood and sexual side-effects from combined oral contraceptives? Hur vanligt är det med humör- och sexuella biverkningar av p-piller? bad-data
Ongoing 2013-001244-56 An open, multicenter, single dose, parallel study, evaluating the pharmacokinetics of doxorubicin and its active metabolite (doxorubicinol) after a hepatic intra-arterial injection of either a lipiodo... not-yet-due
Exempt, with results 2013-001393-19 CD19-targeting 3rd generation CAR T cells for refractory B cell malignancy - a phase I/IIa trial. 2017-05-31 not-yet-due
Reported results 2013-002736-24 Does Ticagrelor inhibit growth of small abdominal aortic aneurysms? A randomised controlled trial (TicAAA) 2017-08-18 due-trials
Exempt 2014-000614-64 Study of recombinant adenovirus in patients with neuroendocrine neoplasms; safety and efficacy not-yet-due
Not reported 2014-000993-20 Dosing of intraarticular triamcinolone hexacetonid for knee synovitis in chronic polyarthritis 2017-11-13 due-trials
Reported results 2014-003432-39 A 24-week, single centre, randomized, parallel-group, double-blind, placebo controlled Phase II study to evaluate the efficacy on body weight of dapagliflozin 10 mg once daily in combination with exen... 2016-03-14 due-trials
Ongoing 2014-005416-42 Clondine in repeated doses for children in pain - a farmacokinetic study Klonidin i upprepade doser för barn med smärta - en farmakokinetisk studie not-yet-due
Not reported 2015-001628-45 A parallel, double-blinded, randomized, 6 months, two arms study with lifestyle intervention and exenatide 2 mg once weekly or lifestyle intervention and placebo in adolescents with obesity to explore... 2016-09-13 due-trials
Reported results 2015-003049-24 The Precision Hypertension Care study 2021-06-11 due-trials
Reported results 2015-005549-30 A single-dose cross-over study to assess direct and indirect effects of dapagliflozin on pancreatic alpha and beta cells in patients with type 2 diabetes 2016-12-01 due-trials
Ongoing 2016-001217-25 Emotion, Serotonin and Premenstrual Dysphoric Disorder (EmSeP) not-yet-due
Ongoing 2016-001719-19 Selecitve progesterone receptor modulators for treatment of premenstrual dysphoric disorder. A randomized, double-blind, placebo controlled study. Selektiv progesteronreceptor-modulerare för behand... not-yet-due
Not reported 2016-003704-31 Impact on the intestinal microbiota during antibiotic treatment Påverkan av tarmens normalflora i samband med antibiotikabehandling 2019-03-29 due-trials
Reported results 2016-004043-36 CD19-TARGETING 3RD GENERATION CAR T CELLS FOR REFRACTORY B CELL MALIGNANCY – A PHASE II TRIAL Behandling av terapiresistent B cells malignitet med CD19-specifika CAR T celler - en fas II studie 2022-01-14 due-trials
Ongoing 2018-000889-11 Randomized Evaluation of Beta Blocker and ACE-Inhibitor/Angiotensin Receptor Blocker Treatment in MINOCA patients - MINOCA-BAT not-yet-due
No trial status on register 2018-002191-41 Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes bad-data
Ongoing 2018-004289-33 Metformin for Abdominal Aortic Aneurysm Inhibition. A randomized controlled trial MAAAGI trial not-yet-due
Ongoing 2019-001046-17 A multicentre, register-based, randomized, controlled trial comparing dapagliflozin with metformin treatment in early stage type 2 diabetes patients by assessing mortality and macro- and microvascular... not-yet-due
Ongoing 2019-001450-26 Can the experience of a diminished effect of local anesthetics be verified by an objective test? not-yet-due
Exempt 2020-005210-18 EFFIPEC – Efficacy of Hyperthermic Intraperitoneal Chemotherapy Single-arm Phase I study, followed by an open-label, randomized, controlled registry-based Phase III trial not-yet-due
Ongoing 2021-001257-31 An open, single center two-step trial (A+B), comparing the safety and tolerability of idarubicin 10 mg and 15 mg after separate single hepatic intra-arterial injections of a drug formulation based on ... not-yet-due
Ongoing 2021-004536-28 Vaginal administration of selective estrogen receptor modulator (Tamoxifen) treatment to improve sexual function for women with breast cancer. A randomized, double-blinded, placebo controlled longitud... not-yet-due